Literature DB >> 20458781

Tide turns for drug manufacturing in Africa.

Tatum Anderson.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20458781     DOI: 10.1016/s0140-6736(10)60687-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Compulsory patent licensing and local drug manufacturing capacity in Africa.

Authors:  Olasupo Ayodeji Owoeye
Journal:  Bull World Health Organ       Date:  2014-01-10       Impact factor: 9.408

2.  The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan.

Authors:  Kumar Perampaladas; Hassan Masum; Andrew Kapoor; Ronak Shah; Abdallah S Daar; Peter A Singer
Journal:  BMC Int Health Hum Rights       Date:  2010-12-13

3.  Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias' in access to imported medicines in Tanzania and its policy implications.

Authors:  Phares G M Mujinja; Maureen Mackintosh; Mary Justin-Temu; Marc Wuyts
Journal:  Global Health       Date:  2014-03-10       Impact factor: 4.185

4.  Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries.

Authors:  Paul N Newton; Kara Hanson; Catherine Goodman
Journal:  Malar J       Date:  2017-05-25       Impact factor: 2.979

5.  The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement.

Authors:  Marion Motari; Jean-Baptiste Nikiema; Ossy M J Kasilo; Stanislav Kniazkov; Andre Loua; Aissatou Sougou; Prosper Tumusiime
Journal:  BMC Public Health       Date:  2021-03-11       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.